Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Akers Biosciences (NQ: AKER )

3.210 USD -0.110 (-3.31%)
Official Closing Price Updated: 5:27 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Akers Biosciences

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline – August 13, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline – AKER
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and certain of its officers. The class action, filed in... 
From GlobeNewswire News Releases
AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15,... 
From Business Wire News Releases
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers Tengasco, Inc. (NYSE: TGC) shares jumped 62.3 percent to $1.42. Anavex Life Sciences Corp (NASDAQ: AVXL) jumped 44 ... 
Tags UONE EPZM PAM
From Benzinga
Benzinga Pro's 5 Stocks To Watch Today
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a ... 
Tags VEON News AVXL
From Benzinga
Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces agreements with six more Independent Sales... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
From ACCESSWIRE
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. (“Akers Biosciences” or the “Company”) (NASDAQ:AKER). 
From Business Wire News Releases
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline - August 13, 2018
From ACCESSWIRE
Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that the Company has requested that trading in the... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
From ACCESSWIRE
AKER NOTICE: Pawar Law Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
From ACCESSWIRE
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Clas
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New... 
From Business Wire News Releases
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. 
From Business Wire News Releases
NASDAQ:AKER Shareholder Notice: Lawsuit Alleges Misleading Statements by Akers Biosciences, Inc
San Diego, CA -- (SBWIRE) -- 06/25/2018 -- An investor, who purchased shares of Akers Biosciences, Inc. (NASDAQ: AKER), filed a lawsuit over alleged violations of Federal Securities Laws by Akers... 
From SBWire - Latest Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER
From ACCESSWIRE
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline – August 13, 2018
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and... 
From GlobeNewswire News Releases
Pomerantz Law Firm Announces the Filing of a Class Action against Akers Biosciences, Inc. and Certain Officers – AKER
Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER) and certain of its officers. The class action, filed in... 
From GlobeNewswire News Releases
Safirstein Metcalf LLP Announces that a Class Action Has Been Filed Against Akers Biosciences, Inc. – AKER
Safirstein Metcalf LLP announces that a class action has been filed on behalf of those who purchased securities of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ:AKER) between May 15, 2017... 
From GlobeNewswire News Releases
AKERS BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Securities Class Action Lawsuit has Been Filed in the United States District Court for the District o
From ACCESSWIRE
Akers Alert: Bernstein Liebhard LLP Announces Investigation of Akers Biosciences, Inc. - AKER
Bernstein Liebhard LLP is investigating potential securities fraud claims on behalf of shareholders of Akers Biosciences, Inc. (“Akers” or the “Company”) (NASDAQ:AKER). If you purchased Akers... 
From GlobeNewswire News Releases
AKERS BIOSCIENCES, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District o
Lead Plaintiff Deadline is August 13, 2018 
From GlobeNewswire News Releases
AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. – AKER
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15,... 
From Business Wire News Releases
Akers Class Action: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. - AKER
Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Akers Biosciences, Inc. (“Akers” or the “Company”)... 
From GlobeNewswire News Releases
Robbins Arroyo LLP: Akers Biosciences, Inc. (AKER) Misled Shareholders According to a Recently Filed Class Action
Do you own shares of Akers Biosciences, Inc.? Robbins Arroyo LLP is investigating claims on behalf of shareholders of Akers. 
From Business Wire News Releases
AKER REMINDER: Pawar Law Reminds of Important August 13, 2018 Lead Plaintiff Deadline in Class Action - AKER
From ACCESSWIRE
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Akers Biosciences, Inc. (Nasdaq: AKER) To Conta
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New... 
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
From ACCESSWIRE
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. 
From Business Wire News Releases
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). 
From PR Newswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.